Literature DB >> 11046191

A novel indication for transvenous lead extraction: upgrading implantable cardioverter defibrillator systems.

V J Korley1, N Hallet, M Daoust, L M Epstein.   

Abstract

UNLABELLED: Technological advances have resulted in the development of dual chamber pacemaker/defibrillator systems with smaller pectoral 'active cans'. Patients now have the option of upgrading from abdominal to pectoral or from single to dual chamber devices. In addition, due to the potential complications which may arise with abandoned ICD leads, extraction of preexisting leads may be preferable. METHODS AND
RESULTS: Twenty consecutive patients (11 males), underwent lead extraction and upgrade, either from an abdominal to a pectoral, or from a single to a dual chamber device. The mean age was 62+/-18 years and mean implant duration was 50+/-14 months. Indications for extraction included lead fracture/malfunction (13), ERI/EOL (2), new SVT/VT (2), long charge times (2), and impending erosion (1). An initial attempt was made to remove the lead with gentle traction. If excessive scar tissue prohibited extraction, then a laser sheath was employed. Reimplantation proceeded following standard protocol. Clinical success was achieved in all patients. Eleven of thirty leads were removed with traction. The remaining 19 leads required removal with the laser sheath. All ICD reimplants were placed in the left pectoral position, of which 10 were dual chamber. The mean defibrillation threshold was 9.5+/-5.8 Joules. There were no procedure related perforations or deaths. At follow up (13+/-10 mos. ) there were no infections, lead malfunctions or venous thromboses. There were two deaths, both from intractable heart failure.
CONCLUSIONS: This study demonstrates that, when indicated, ICD leads can be safely extracted and systems successfully upgraded to take advantage of new technology.

Entities:  

Mesh:

Year:  2000        PMID: 11046191     DOI: 10.1023/a:1009816716541

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  9 in total

1.  Pacemaker lead extraction with the laser sheath: results of the pacing lead extraction with the excimer sheath (PLEXES) trial.

Authors:  B L Wilkoff; C L Byrd; C J Love; D L Hayes; T D Sellers; R Schaerf; V Parsonnet; L M Epstein; R A Sorrentino; C Reiser
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

2.  Initial experience with a laser sheath to extract chronic transvenous implantable cardioverter-defibrillator leads.

Authors:  S C Krishnan; L M Epstein
Journal:  Am J Cardiol       Date:  1998-11-15       Impact factor: 2.778

3.  Learning curve characteristics of pacing lead extraction with a laser sheath.

Authors:  F A Bracke; A Meijer; B Van Gelder
Journal:  Pacing Clin Electrophysiol       Date:  1998-11       Impact factor: 1.976

4.  Large laser sheaths for pacing and defibrillator lead removal.

Authors:  C Reiser; K D Taylor; R A Lippincott
Journal:  Lasers Surg Med       Date:  1998       Impact factor: 4.025

5.  Suppression of a demand pacemaker in the presence of redundant transvenous right ventricular leads.

Authors:  G F Tyers; A J Larrieu; A Nishimura; E H Williams; M Kurusz; R R Brownlee
Journal:  Pacing Clin Electrophysiol       Date:  1980-01       Impact factor: 1.976

6.  Initial experience with larger laser sheaths for the removal of transvenous pacemaker and implantable defibrillator leads.

Authors:  L M Epstein; C L Byrd; B L Wilkoff; C J Love; T D Sellers; D L Hayes; C Reiser
Journal:  Circulation       Date:  1999-08-03       Impact factor: 29.690

7.  The incidence of venous thrombosis following long-term transvenous pacing.

Authors:  W S Stoney; R B Addlestone; W C Alford; G R Burrus; R A Frist; C S Thomas
Journal:  Ann Thorac Surg       Date:  1976-08       Impact factor: 4.330

8.  Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads.

Authors:  A E Epstein; G N Kay; V J Plumb; S M Dailey; P G Anderson
Journal:  Circulation       Date:  1998-10-13       Impact factor: 29.690

9.  Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators.

Authors:  D P Zipes; D Roberts
Journal:  Circulation       Date:  1995-07-01       Impact factor: 29.690

  9 in total
  1 in total

Review 1.  Considerations for cardiac device lead extraction.

Authors:  Oussama Wazni; Bruce L Wilkoff
Journal:  Nat Rev Cardiol       Date:  2016-01-29       Impact factor: 32.419

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.